GTF2I and thymoma: Additionally, case studies that performed NGS found genomic aberrations in thymomas, such as GTF2I [14,15], ASXL2, DNMT3A [16], KRAS, HRAS [17], CDKN2A/B [18], and TP53 [18], as well as chromosomal abnormalities [19,20].